acarix Corporate Information, IR, Listing Regulation, News, Other Corporate Information, Regulatory, Swedish November 18, 2024 06 Mar 2024 Idag inleds utnyttjandeperioden för Acarix teckningsoptioner av serie 2024:U1 (TO2) Utnyttjandeperioden för de teckningsoptioner av serie 2024:U1 (TO2) (”Teckningsoptioner”) som emitterades i samband me... Continue reading
acarix Corporate Information, English, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM November 18, 2024 21 Feb 2024 Announcement from Acarix’s extra general meeting The extra general meeting of Acarix AB (the "Company") was held today on 21 February 2024 and the following resolution was passed by th... Continue reading
acarix Corporate Information, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM, Swedish November 18, 2024 21 Feb 2024 Kommuniké från extra bolagsstämma i Acarix Extra bolagsstämma i Acarix AB ("Bolaget") hölls idag den 21 februari 2024 varvid aktieägarna fattade följande besl... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 15 Feb 2024 Acarix strengthens US Advisory Board with three industry leaders New York, New York, February 15, 2024 – Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces the appointmen... Continue reading
acarix Corporate Information, IR, News, Other Corporate Information, Swedish November 18, 2024 15 Feb 2024 Acarix expanderar USA-baserat Advisory Board med tre nya rådgivare New York, New York, 15 februari 2024 – Acarix, ledande inom akustisk- och algoritmbaserad hjärtdiagnostik, har utnämnt ... Continue reading
acarix English, Interim, IR, Listing Regulation, News, Regulatory, Report, Yearend November 18, 2024 15 Feb 2024 Acarix AB (publ) publishes Year-End Report 2023 Embarking on a new journey with focus on sustainable growthAs the newly appointed CEO of Acarix, I am honored to be on board and share ... Continue reading
acarix Interim, IR, Listing Regulation, News, Regulatory, Report, Swedish, Yearend November 18, 2024 15 Feb 2024 Acarix AB (publ) publicerar Bokslutskommuniké 2023 Fokus mot USA och hållbar tillväxtSom nyutnämnd VD är jag hedrad att få leda Acarix och dela en del av v&ari... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 14 Feb 2024 Invitation to presentation of Acarix´s fourth quarter report Acarix will publish its fourth quarter results on Thursday 15 February 2024 at 08.00 am (CEST). A live webcast will be held at 15.00 (C... Continue reading
acarix Corporate Information, IR, News, Other Corporate Information, Swedish November 18, 2024 14 Feb 2024 Inbjudan till presentation av Acarix delårsrapport för fjärde kvartalet 2023 Acarix publicerar sin rapport för fjärde kvartalet på torsdag den 15 februari 2024 kl 08.00. En direktsänd webbs&a... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 02 Feb 2024 Acarix CADScor System now listed on US Federal Supply Schedule Acarix, a leader in advanced acoustic and algorithm based cardiac diagnostic devices today announces that its CADScor System has been a... Continue reading
acarix Corporate Information, IR, News, Other Corporate Information, Swedish November 18, 2024 02 Feb 2024 Acarix CADScor System är nu listat på US Federal Supply Schedule Acarix, ledande inom avancerad akustisk- och algoritmbaserad hjärtdiagnostik, meddelar idag att CADScor System har adderats till d... Continue reading
acarix Corporate Information, English, General meeting, IR, Listing Regulation, News, Notice, Regulatory November 18, 2024 01 Feb 2024 NOTICE OF EXTRA GENERAL MEETING IN ACARIX AB The shareholders of Acarix AB, reg. no. 559009-0667 (the "Company"), are hereby invited to the extra general meeting on Wednesday 21 Fe... Continue reading